Phase 1 ANCA Associated Vasculitis (AAV) Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

CAR T-cell Therapy Targeting CD19 and BCMA(QT-019C) in Patients With Relapse/Refractory Autoimmune Diseases

ANCA Associated Vasculitis (AAV)SLE - Systemic Lupus ErythematosusSSc-Systemic Sclerosis+3 more

Institute of Hematology & Blood Diseases Hospital, China12 enrolled1 locationNCT07315087

Recruiting

Phase 1Phase 2

Safety and Efficacy of Universal CD19-targeting CAR-γδT Cells in Refractory Autoimmune Diseases

Sjogren SyndromeSystemic Lupus ErthematosusSystemic Sclerosis (SSc)+3 more

Peking University Third Hospital9 enrolled1 locationNCT06828042

Recruiting

Phase 1

A Study of OL-108 in Relapsed/Refractory Autoimmune Diseases

Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Idiopathic Inflammatory Myopathy (IIM)+1 more

Beijing GoBroad Hospital44 enrolled2 locationsNCT06980597